Clinical Trials Logo

Clinical Trial Summary

The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus.

The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk.

In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04452630
Study type Observational
Source Assistance Publique Hopitaux De Marseille
Contact Franck THUNY, MD
Email franck.thuny@ap-hm.fr
Status Recruiting
Phase
Start date June 23, 2020
Completion date November 30, 2021